GSEP
CCXI

Golden State Equity Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Golden State Equity Partners’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,600
Closed -$209K – 287
2021
Q2 		$209K Buy
+15,600
New +$384K 0.08% 225

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Golden State Equity Partners's CCXI Position: Q3 2021 in Review

Golden State Equity Partners sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 15,600 shares — an estimated $209K sold.

Golden State Equity Partners first reported a position in CCXI in Q2 2021 and held it in 1 quarter. The position peaked at $209K in Q2 2021. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

  • Golden State Equity Partners reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
  • Golden State Equity Partners sold 15,600 ChemoCentryx, Inc. shares in Q3 2021, an estimated $209K.
  • Golden State Equity Partners first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 1 quarter.
  • Golden State Equity Partners's ChemoCentryx, Inc. position peaked at $209K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Golden State Equity Partners's 13F filing for Q3 2021, filed 15 Nov 2021.